vs
Foghorn Therapeutics Inc.（FHTX）与VerifyMe, Inc.（VRME）财务数据对比。点击上方公司名可切换其他公司
Foghorn Therapeutics Inc.的季度营收约是VerifyMe, Inc.的1.8倍（$9.2M vs $5.0M），VerifyMe, Inc.净利率更高（-66.7% vs -234.3%，领先167.6%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs -7.4%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs -5.2%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
VerifyMe, Inc.是一家专注于身份核验、防伪溯源及品牌保护服务的科技企业，为消费品、制药、零售等行业客户提供安全认证工具、全链路溯源系统与用户互动解决方案，业务覆盖北美及多个海外市场。
FHTX vs VRME — 直观对比
营收规模更大
FHTX
是对方的1.8倍
$5.0M
营收增速更快
FHTX
高出231.2%
-7.4%
净利率更高
VRME
高出167.6%
-234.3%
两年增速更快
FHTX
近两年复合增速
-5.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $5.0M |
| 净利润 | $-21.7M | $-3.4M |
| 毛利率 | — | 41.2% |
| 营业利润率 | -258.2% | -68.2% |
| 净利率 | -234.3% | -66.7% |
| 营收同比 | 223.8% | -7.4% |
| 净利润同比 | -11.1% | -38.4% |
| 每股收益（稀释后） | $-0.35 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXVRME
| Q4 25 | $9.2M | — | ||
| Q3 25 | $8.2M | $5.0M | ||
| Q2 25 | $7.6M | $4.5M | ||
| Q1 25 | $6.0M | $4.5M | ||
| Q4 24 | $2.9M | — | ||
| Q3 24 | $7.8M | $5.4M | ||
| Q2 24 | $6.9M | $5.4M | ||
| Q1 24 | $5.0M | $5.8M |
净利润FHTXVRME
| Q4 25 | $-21.7M | — | ||
| Q3 25 | $-15.8M | $-3.4M | ||
| Q2 25 | $-17.9M | $-291.0K | ||
| Q1 25 | $-18.8M | $-571.0K | ||
| Q4 24 | $-19.5M | — | ||
| Q3 24 | $-19.1M | $-2.4M | ||
| Q2 24 | $-23.0M | $-346.0K | ||
| Q1 24 | $-25.0M | $-553.0K |
毛利率FHTXVRME
| Q4 25 | — | — | ||
| Q3 25 | — | 41.2% | ||
| Q2 25 | — | 35.2% | ||
| Q1 25 | — | 33.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 34.9% | ||
| Q2 24 | — | 39.1% | ||
| Q1 24 | — | 39.2% |
营业利润率FHTXVRME
| Q4 25 | -258.2% | — | ||
| Q3 25 | -226.9% | -68.2% | ||
| Q2 25 | -279.2% | -7.1% | ||
| Q1 25 | -385.0% | -13.3% | ||
| Q4 24 | -840.5% | — | ||
| Q3 24 | -305.5% | -52.8% | ||
| Q2 24 | -386.6% | -10.0% | ||
| Q1 24 | -558.3% | -11.2% |
净利率FHTXVRME
| Q4 25 | -234.3% | — | ||
| Q3 25 | -194.4% | -66.7% | ||
| Q2 25 | -237.3% | -6.4% | ||
| Q1 25 | -316.4% | -12.8% | ||
| Q4 24 | -682.9% | — | ||
| Q3 24 | -244.9% | -44.6% | ||
| Q2 24 | -333.6% | -6.5% | ||
| Q1 24 | -495.4% | -9.6% |
每股收益（稀释后）FHTXVRME
| Q4 25 | $-0.35 | — | ||
| Q3 25 | $-0.25 | $-0.26 | ||
| Q2 25 | $-0.28 | $-0.02 | ||
| Q1 25 | $-0.30 | $-0.05 | ||
| Q4 24 | $-0.23 | — | ||
| Q3 24 | $-0.31 | $-0.23 | ||
| Q2 24 | $-0.45 | $-0.03 | ||
| Q1 24 | $-0.59 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-108.5M | $11.1M |
| 总资产 | $198.1M | $13.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FHTXVRME
| Q4 25 | $80.9M | — | ||
| Q3 25 | $89.3M | — | ||
| Q2 25 | $72.6M | — | ||
| Q1 25 | $61.0M | — | ||
| Q4 24 | $55.5M | — | ||
| Q3 24 | $57.7M | $2.6M | ||
| Q2 24 | $138.9M | $2.9M | ||
| Q1 24 | $79.3M | $2.8M |
总债务FHTXVRME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $500.0K | ||
| Q2 24 | — | $600.0K | ||
| Q1 24 | — | $800.0K |
股东权益FHTXVRME
| Q4 25 | $-108.5M | — | ||
| Q3 25 | $-89.7M | $11.1M | ||
| Q2 25 | $-76.7M | $14.4M | ||
| Q1 25 | $-61.7M | $14.6M | ||
| Q4 24 | $-45.5M | — | ||
| Q3 24 | $-28.3M | $10.3M | ||
| Q2 24 | $-14.3M | $12.3M | ||
| Q1 24 | $-97.5M | $12.4M |
总资产FHTXVRME
| Q4 25 | $198.1M | — | ||
| Q3 25 | $205.0M | $13.3M | ||
| Q2 25 | $226.2M | $17.2M | ||
| Q1 25 | $258.7M | $17.1M | ||
| Q4 24 | $284.0M | — | ||
| Q3 24 | $308.4M | $14.8M | ||
| Q2 24 | $328.6M | $17.5M | ||
| Q1 24 | $255.0M | $17.9M |
负债/权益比FHTXVRME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.05× | ||
| Q1 24 | — | 0.06× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | $243.0K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FHTXVRME
| Q4 25 | $-22.3M | — | ||
| Q3 25 | $-18.9M | $243.0K | ||
| Q2 25 | $-21.0M | $710.0K | ||
| Q1 25 | $-24.0M | $-404.0K | ||
| Q4 24 | $-24.5M | — | ||
| Q3 24 | $-21.0M | $-10.0K | ||
| Q2 24 | $-25.5M | $372.0K | ||
| Q1 24 | $-29.3M | $-60.0K |
自由现金流FHTXVRME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-21.0M | — | ||
| Q1 25 | $-24.0M | — | ||
| Q4 24 | $-25.0M | — | ||
| Q3 24 | $-21.3M | $-12.0K | ||
| Q2 24 | $-25.6M | $369.0K | ||
| Q1 24 | $-29.4M | $-62.0K |
自由现金流率FHTXVRME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -278.2% | — | ||
| Q1 25 | -403.2% | — | ||
| Q4 24 | -875.3% | — | ||
| Q3 24 | -273.0% | -0.2% | ||
| Q2 24 | -371.0% | 6.9% | ||
| Q1 24 | -583.1% | -1.1% |
资本支出强度FHTXVRME
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 4.0% | 0.0% | ||
| Q2 24 | 0.2% | 0.1% | ||
| Q1 24 | 2.0% | 0.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FHTX
暂无分部数据
VRME
| Proactive Services | $4.2M | 83% |
| Other | $869.0K | 17% |
